Superworth

Indivior Pharmaceuticals profit margin INDV

Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.

Net margin, 12 months
26.7%
Operating margin, 12 months
31.6%
Net margin on a year earlier
+17.5 pts
Peer median
12.6%

Over the twelve months to Jun 30, 2026, Indivior Pharmaceuticals kept 26.7% of its revenue as net profit, with an operating margin of 31.6% and a gross margin of 82.1%.

The median for 10 large drugmakers of a similar size is 12.6%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY202516.9%21.1%80.1%
FY20240.6%3.2%80.5%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY2626.7%+17.5 pts31.6%
Q1 FY2619.4%+20.0 pts25.8%
Q4 FY2516.9%+16.3 pts21.1%
Q3 FY2510.8%n/a19.2%
Q2 FY259.2%n/a18.7%
Q1 FY25−0.6%n/a2.5%
Q4 FY240.6%n/a3.2%
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24n/an/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Indivior Pharmaceuticals' size, closest first, today.

CompanyProfit margin
INDVIndivior Pharmaceuticals26.7%
ARQTArcutis Biotherapeutics6.1%
LQDALiquidia30.7%
OGNOrganon3.4%
NRIXNurix Therapeutics42.0%
KNSAKiniksa Pharmaceuticals International9.6%
LGNDLigand Pharmaceuticals67.9%
AMRXAmneal Pharmaceuticals5.0%
PBHPrestige Consumer Healthcare15.6%
ALKSAlkermes plc.4.0%
HRMYHarmony Biosciences18.9%
Peer median12.6%

Where Indivior Pharmaceuticals ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Indivior Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.